Trial intelligence / Profile preview

Rosuvastatin in Systemic Lupus Erythematosus

NCT01170585Phase 2Completed

Sponsor
Imperial College London
Start
Jul 2010
Primary completion
May 2014
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of rosuvastatin in atherosclerosis, sponsored by Imperial College London. Started Jul 2010; status: completed.

02

Drugs

rosuvastatin
03

Conditions

atherosclerosis

Beyond the preview

Go deeper on NCT01170585.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01170585.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call